Zika Virus: Transmission, Symptoms and Laboratory Diagnosis

Infectious Disease Research | Virology

Zika Virus: Transmission, Symptoms and Laboratory Diagnosis

Understanding Zika virus infection, antibody testing and the importance of accurate laboratory interpretation.

Introduction to Zika Virus

Zika virus (ZIKV) is an arthropod-borne virus belonging to the Flavivirus genus, a group that also includes dengue, yellow fever and Japanese encephalitis viruses. It is primarily transmitted through the bite of infected Aedes mosquitoes, particularly Aedes aegypti.

Although many Zika virus infections are asymptomatic, some individuals develop mild symptoms. The virus is also important in maternal and fetal health because infection during pregnancy can lead to congenital abnormalities and other serious complications.

Understanding its transmission routes, clinical presentation and diagnostic methods is essential for healthcare professionals, clinical laboratories and infectious disease researchers.

How Is Zika Virus Transmitted?

Zika virus is mainly transmitted through infected Aedes mosquitoes, which are active primarily during the day. Other documented transmission routes include:

  • Mosquito bites: The primary route of transmission through infected Aedes mosquitoes.
  • Mother-to-child transmission: Infection can pass from a pregnant woman to her fetus.
  • Sexual transmission: The virus can be transmitted through sexual contact.
  • Blood exposure: Transmission through blood transfusion has been documented.

Common Symptoms of Zika Virus Infection

Most people infected with Zika virus do not develop noticeable symptoms. When symptoms occur, they are generally mild and may include:

  • Fever.
  • Skin rash.
  • Conjunctivitis (red eyes).
  • Muscle and joint pain.
  • Headache.
  • General fatigue and malaise.

Symptoms commonly last between two and seven days. However, Zika virus infection during pregnancy can cause congenital Zika syndrome, including microcephaly and other developmental abnormalities. Medical assessment is particularly important when infection is suspected during pregnancy.

Laboratory Diagnosis of Zika Virus

Because Zika symptoms can resemble those of other mosquito-borne infections, including dengue and chikungunya, laboratory testing plays an important role in diagnostic assessment.

1. Molecular Testing (RT-PCR / NAAT)

Molecular assays detect Zika virus genetic material in clinical specimens. A positive nucleic acid amplification test can provide evidence of infection. However, the period during which viral RNA can be detected is limited, so a negative result does not always exclude recent infection.

2. Serological Testing (IgM and IgG Antibodies)

Serological tests detect antibodies produced by the immune system in response to viral exposure.

  • IgM antibodies: May indicate a recent immune response, although they can persist for months or longer.
  • IgG antibodies: May indicate previous exposure or an established immune response.

Antibody testing can support laboratory investigations, but results must be interpreted carefully alongside clinical history, exposure information and other diagnostic findings.

3. Confirmatory Testing

Because Zika and dengue viruses belong to the same virus family, antibodies may cross-react between these viruses. Additional laboratory investigations, including plaque reduction neutralization testing (PRNT) where appropriate, may help clarify ambiguous serological results.

Why Is Cross-Reactivity Important?

One of the main challenges in Zika serology is antibody cross-reactivity with other flaviviruses, particularly dengue virus. Previous infections or vaccination against related flaviviruses may influence antibody test results.

This means that a positive Zika IgM or IgG result does not automatically establish a confirmed Zika virus infection. Healthcare professionals should consider local epidemiology, patient history and appropriate confirmatory testing when interpreting results.

Important Diagnostic Consideration

Serological screening should not be used as the sole basis for diagnosing Zika virus infection. Molecular testing and additional confirmatory investigations may be required depending on the clinical situation.

Zika Virus Prevention

Preventing mosquito bites remains an important strategy for reducing Zika virus transmission. Recommended preventive measures include:

  • Using appropriate insect repellents.
  • Wearing long-sleeved clothing and long trousers.
  • Using window and door screens or mosquito nets when appropriate.
  • Removing standing water where mosquitoes can breed.
  • Following public health guidance on sexual transmission prevention, particularly during pregnancy.
Featured Diagnostic Product

Zika Virus IgG/IgM Rapid Test

Zika Virus IgG/IgM Rapid Test - Gentaur

The Gentaur Zika Virus IgG/IgM Rapid Test is a cassette-based immunological screening device designed for the qualitative detection of IgG and IgM antibodies against Zika virus in human whole blood, serum or plasma samples.

It can support preliminary serological investigations in professional diagnostic settings. Results should be interpreted with clinical and epidemiological information and, when necessary, confirmed using appropriate laboratory methods.

Catalog Number: 1317-GS110421C

Pack Size: 25 Tests/box

Sample Type: Whole Blood / Serum / Plasma

Format: Cassette 4 mm

Storage: 0–40 °C

Supplier: Riomavix Sociedad Limitada, Spain

VIEW PRODUCT

Related Rapid Diagnostic Tests

Explore other antibody-based rapid screening tests available from Gentaur:

Catalog Number Product
GS110424C Nipah Virus IgG/IgM Rapid Test
GS110430C JEV IgG/IgM Rapid Test
GS111101C Brucella IgG/IgM Rapid Test
GS110126C TB IgG/IgM Rapid Test
GS110137C Measles IgG/IgM Rapid Test
GS110517C Typhoid IgG/IgM Rapid Test
GS110418C Chikungunya IgG/IgM Rapid Test
GS110429C Hantavirus IgG/IgM Rapid Test
GS110236C HAV IgM/IgG Rapid Test
GS110407C Dengue IgM/IgG Rapid Test

Conclusion

Zika virus remains an important subject in infectious disease research and public health, particularly because of its mosquito-borne transmission and potential complications during pregnancy. Accurate laboratory assessment requires an understanding of both molecular and serological testing methods.

Antibody-based rapid tests can contribute to preliminary screening workflows, but cross-reactivity with related flaviviruses must be considered. Appropriate clinical assessment and confirmatory laboratory testing remain essential for reliable interpretation.

Scientific References

  1. World Health Organization (WHO). Zika Virus – Fact Sheet.
  2. Centers for Disease Control and Prevention (CDC). Clinical Testing and Diagnosis for Zika Virus Disease.
  3. World Health Organization (WHO). Laboratory Testing for Zika Virus and Dengue Virus Infections: Interim Guidance.

Explore Diagnostic Products at Gentaur

Discover rapid diagnostic tests, antibodies, laboratory reagents and research products.

EXPLORE GENTAUR
16th Nov 2026

Recent Posts